Genes and Mutations: Understanding BRC1 and BRC2

Alex and Rosa Dembitzer - Northern Charitable Foundation - understanding BRCA gene mutations

All women are at risk of developing breast cancer during their lifetime. There are various risk factors that can increase the likelihood, one of them being genetic susceptibility. Genes are segments of DNA (deoxyribonucleic acid), and DNA makes up chromosomes. Humans have 23 pairs of chromosomes, receiving half of each pair from the mother and … Read more

The Signs of Ovarian Cancer: Know What to Look For

Dembitzer - Northern Charitable Foundation - the sings of ovarian cancer

Cancer, a word everyone is familiar with, is a term for diseases that can affect any part of the body. These diseases are caused by the rapid, abnormal growth of cells that have the potential to extend beyond their normal boundaries into other parts of the body and organs. When diagnosed and treated in the … Read more

What Is Triple-Negative Breast Cancer and How Does It Relate To The BRCA Gene Mutation?

Northern Charitable Foundation - Rosa and Alex Dembitzer - Breast cancer information

Triple-Negative Breast Cancer (TNBC) is an aggressive form of breast cancer which spreads and grows rapidly in the body. Approximately 10-15% of all breast cancers are TNCB, named triple-negative for its negative testing of three molecular components – estrogen, progesterone, and human epidermal growth factor (HER2). This cancer is more likely to return than other … Read more

Why The Northern Charitable Foundation Sponsors the Prevention GENEration Program

Rosa Dembitzer - Breast cancer awareness month

We are very passionate about sponsoring the Israel Cancer Association’s Prevention GENEration Program in collaboration with The Israel Hereditary Breast and Ovarian Cancer Consortium. The aim of the program is to reduce cancer morbidity in Israel by promoting research, prevention, early detection, treatment modalities, and means of rehabilitation. The High Rate of Individuals with the … Read more

New Parp Inhibitor Lynparza May Be Important Tool for Treating Early-Stage Breast Cancer

Northern Charitable Foundation - breast cancer research

The President of the American Society for Clinical Oncology shared that new research has found that the Lynparza parp inhibitor could have a significant impact on the treatment and decision paths of patients with both high-risk and early-stage breast cancer. The study also showed that Lynparza reduces the chances that patients with the BRCA gene … Read more

Be proactive, take the BRCA test and save your own life.

Diagnosed with BRCA When I was diagnosed with breast cancer, I knew nothing of the BRCA gene. My friend mentioned it in a conversation, “ Will you get tested for the Jewish Gene?” When I raised this question to my surgeon, she said we should do it, get tested, but proceed with the surgery as … Read more